Insights into Nanomedicine for Head and Neck Cancer Diagnosis and Treatment

Overview

Journal Materials (Basel)

Publisher MDPI

Date 2022 Mar 25

PMID 35329542

Authors

Claudia Viegas

Daniela S M Pereira

Pedro Fonte

Affiliations

Soon will be listed here.

Abstract

Head and neck cancers rank sixth among the most common cancers today, and the survival rate has remained virtually unchanged over the past 25 years, due to late diagnosis and ineffective treatments. They have two main risk factors, tobacco and alcohol, and human papillomavirus infection is a secondary risk factor. These cancers affect areas of the body that are fundamental for the five senses. Therefore, it is necessary to treat them effectively and non-invasively as early as possible, in order to do not compromise vital functions, which is not always possible with conventional treatments (chemotherapy or radiotherapy). In this sense, nanomedicine plays a key role in the treatment and diagnosis of head and neck cancers. Nanomedicine involves using nanocarriers to deliver drugs to sites of action and reducing the necessary doses and possible side effects. The main purpose of this review is to give an overview of the applications of nanocarrier systems to the diagnosis and treatment of head and neck cancer. Herein, several types of delivery strategies, radiation enhancement, inside-out hyperthermia, and theragnostic approaches are addressed.

Citing Articles

New insights of cerium oxide nanoparticles in head and neck cancer treatment.

Tarakci E, Esmkhani S, Bayramova J, Bilgin F, Kidik K, Adiguzel S Sci Rep. 2025; 15(1):7665.

PMID: 40044797 PMC: 11883070. DOI: 10.1038/s41598-025-85228-3.

Revolutionizing head and neck squamous cell carcinoma treatment with nanomedicine in the era of immunotherapy.

Li H, Gong Y, Yan P, Xu Y, Qin G, Wen W Front Immunol. 2024; 15:1453753.

PMID: 39676875 PMC: 11638222. DOI: 10.3389/fimmu.2024.1453753.

Radiopharmaceuticals: navigating the frontier of precision medicine and therapeutic innovation.

Dhoundiyal S, Srivastava S, Kumar S, Singh G, Ashique S, Pal R Eur J Med Res. 2024; 29(1):26.

PMID: 38183131 PMC: 10768149. DOI: 10.1186/s40001-023-01627-0.

Advances in Pancreatic Cancer Treatment by Nano-Based Drug Delivery Systems.

Viegas C, Patricio A, Prata J, Fonseca L, Macedo A, Duarte S Pharmaceutics. 2023; 15(9).

PMID: 37765331 PMC: 10536303. DOI: 10.3390/pharmaceutics15092363.

Insights into Gold Nanoparticles Possibilities for Diagnosis and Treatment of the Head and Neck Upper Aerodigestive Tract Cancers.

Andrade L, Costa G Cancers (Basel). 2023; 15(7).

PMID: 37046740 PMC: 10093449. DOI: 10.3390/cancers15072080.

References

Lenouvel D, Gonzalez-Moles M, Talbaoui A, Ramos-Garcia P, Gonzalez-Ruiz L, Ruiz-Avila I . An update of knowledge on PD-L1 in head and neck cancers: Physiologic, prognostic and therapeutic perspectives. Oral Dis. 2019; 26(3):511-526. DOI: 10.1111/odi.13088. View

Xu Q, Fang M, Zhu J, Dong H, Cao J, Yan L . Insights into Nanomedicine for Immunotherapeutics in Squamous Cell Carcinoma of the head and neck. Int J Biol Sci. 2020; 16(14):2506-2517. PMC: 7415431. DOI: 10.7150/ijbs.47068. View

Wu J . The Enhanced Permeability and Retention (EPR) Effect: The Significance of the Concept and Methods to Enhance Its Application. J Pers Med. 2021; 11(8). PMC: 8402171. DOI: 10.3390/jpm11080771. View

de Lazaro I, Mooney D . Obstacles and opportunities in a forward vision for cancer nanomedicine. Nat Mater. 2021; 20(11):1469-1479. DOI: 10.1038/s41563-021-01047-7. View

Al Qaraghuli M . Biotherapeutic Antibodies for the Treatment of Head and Neck Cancer: Current Approaches and Future Considerations of Photothermal Therapies. Front Oncol. 2020; 10:559596. PMC: 7726427. DOI: 10.3389/fonc.2020.559596. View

Irby R, Yeatman T . Role of Src expression and activation in human cancer. Oncogene. 2000; 19(49):5636-42. DOI: 10.1038/sj.onc.1203912. View

Herskovic A, Martz K, Al-Sarraf M, Leichman L, Brindle J, Vaitkevicius V . Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med. 1992; 326(24):1593-8. DOI: 10.1056/NEJM199206113262403. View

Staal A, Becker K, Tagit O, van Riessen N, Koshkina O, Veltien A . In vivo clearance of F MRI imaging nanocarriers is strongly influenced by nanoparticle ultrastructure. Biomaterials. 2020; 261:120307. DOI: 10.1016/j.biomaterials.2020.120307. View

Beik J, Abed Z, Ghoreishi F, Hosseini-Nami S, Mehrzadi S, Shakeri-Zadeh A . Nanotechnology in hyperthermia cancer therapy: From fundamental principles to advanced applications. J Control Release. 2016; 235:205-221. DOI: 10.1016/j.jconrel.2016.05.062. View

10.

Riley R, Day E . Gold nanoparticle-mediated photothermal therapy: applications and opportunities for multimodal cancer treatment. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017; 9(4). PMC: 5474189. DOI: 10.1002/wnan.1449. View

11.

Peer D, Karp J, Hong S, Farokhzad O, Margalit R, Langer R . Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2008; 2(12):751-60. DOI: 10.1038/nnano.2007.387. View

12.

Alexis F, Rhee J, Richie J, Radovic-Moreno A, Langer R, Farokhzad O . New frontiers in nanotechnology for cancer treatment. Urol Oncol. 2008; 26(1):74-85. DOI: 10.1016/j.urolonc.2007.03.017. View

13.

Fonte P, Andrade F, Azevedo C, Pinto J, Seabra V, van de Weert M . Effect of the Freezing Step in the Stability and Bioactivity of Protein-Loaded PLGA Nanoparticles Upon Lyophilization. Pharm Res. 2016; 33(11):2777-93. DOI: 10.1007/s11095-016-2004-3. View

14.

Wang B, Wang J, Liu Q, Huang H, Chen M, Li K . Rose-bengal-conjugated gold nanorods for in vivo photodynamic and photothermal oral cancer therapies. Biomaterials. 2013; 35(6):1954-66. DOI: 10.1016/j.biomaterials.2013.11.066. View

15.

Gao S, Zheng M, Ren X, Tang Y, Liang X . Local hyperthermia in head and neck cancer: mechanism, application and advance. Oncotarget. 2016; 7(35):57367-57378. PMC: 5302995. DOI: 10.18632/oncotarget.10350. View

16.

Simonet S, Rodriguez-Lafrasse C, Beal D, Gerbaud S, Malesys C, Tillement O . Gadolinium-Based Nanoparticles Can Overcome the Radioresistance of Head and Neck Squamous Cell Carcinoma Through the Induction of Autophagy. J Biomed Nanotechnol. 2020; 16(1):111-124. DOI: 10.1166/jbn.2020.2871. View

17.

Vokes E, Weichselbaum R, Lippman S, Hong W . Head and neck cancer. N Engl J Med. 1993; 328(3):184-94. DOI: 10.1056/NEJM199301213280306. View

18.

Kudr J, Haddad Y, Richtera L, Heger Z, cernak M, Adam V . Magnetic Nanoparticles: From Design and Synthesis to Real World Applications. Nanomaterials (Basel). 2017; 7(9). PMC: 5618354. DOI: 10.3390/nano7090243. View

19.

Bobo D, Robinson K, Islam J, Thurecht K, Corrie S . Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date. Pharm Res. 2016; 33(10):2373-87. DOI: 10.1007/s11095-016-1958-5. View

20.

Pezzuto F, Buonaguro L, Caponigro F, Ionna F, Starita N, Annunziata C . Update on Head and Neck Cancer: Current Knowledge on Epidemiology, Risk Factors, Molecular Features and Novel Therapies. Oncology. 2015; 89(3):125-36. DOI: 10.1159/000381717. View